Litcius/Paper detail

Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

Won Seog Kim, Yasuhiro Oki, Seok Jin Kim, Sang Eun Yoon, Kirit M. Ardeshna, Yi Lin, Jia Ruan, Pierluigi Porcu, Jonathan E. Brammer, Eric D. Jacobsen, Dok Hyun Yoon, Cheolwon Suh, Felipe Suárez, John Radford, Lihua E. Budde, Jin Seok Kim, Emmanuel Bachy, Hun Ju Lee, Catherine M. Bollard, Arnaud Jaccard, Hye Jin Kang, Shannon Inman, Maryann Murray, Katherin E. Combs, Daniel Y. Lee, Ranjana H. Advani, Kurt C. Gunter, Cliona M. Rooney, Helen E. Heslop

2021Annals of Hematology24 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineCohortLymphomaHematologyClinical trialGastroenterologyAdjuvantSalvage therapyT-cell lymphomaSurgeryOncologyChemotherapyLymphoma Diagnosis and TreatmentViral-associated cancers and disordersCAR-T cell therapy research
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study | Litcius